Ikarian Capital’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.57M Sell
469,949
-25,000
-5% -$350K 1.26% 16
2025
Q1
$6.67M Buy
494,949
+25,000
+5% +$337K 0.82% 14
2024
Q4
$9.01M Sell
469,949
-30,028
-6% -$576K 1.23% 6
2024
Q3
$11.4M Buy
+499,977
New +$11.4M 1.59% 5
2024
Q2
Hold
0
110
2024
Q1
Hold
0
118
2022
Q3
Hold
0
119
2022
Q2
Hold
0
161